BioCentury | May 29, 2019
Financial News

How cancer play Pi plans to deploy $19.7M series B

...and solid tumor indications based on technology licensed from Johns Hopkins University. Founded in 2015, Pi Therapeutics...
...Zafrira Avnur, Arkin's Pini Orbach and CBG's Merav Kaye will join Pi's board. Mark Zipkin, Staff Writer Pi Therapeutics Proteasome protein...
Items per page:
1 - 1 of 1
BioCentury | May 29, 2019
Financial News

How cancer play Pi plans to deploy $19.7M series B

...and solid tumor indications based on technology licensed from Johns Hopkins University. Founded in 2015, Pi Therapeutics...
...Zafrira Avnur, Arkin's Pini Orbach and CBG's Merav Kaye will join Pi's board. Mark Zipkin, Staff Writer Pi Therapeutics Proteasome protein...
Items per page:
1 - 1 of 1